English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduScientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
Tag: Diabetes
Light or moderate alcohol consumption does not guard against diabetes, obesity
People who have just one or two drinks per day are not protected against endocrine conditions such as obesity and type 2 diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Nationwide Children’s Hospital Marks A Decade as One of the Nation’s Best
Nationwide Children’s Hospital has been named to U.S. News & World Report’s Best Children’s Hospitals Honor Roll for the 10th consecutive year. The Honor Roll is a top distinction awarded to only 10 children’s hospitals nationwide recognized by U.S. News as the “Best of the Best.” Nationwide Children’s is ranked sixth on the 2023-24 Honor Roll list.
CGM alarms often not set to alert children with diabetes to harmful blood glucose fluctuations
Children and teenagers who use continuous glucose monitors (CGM) to manage diabetes often fail to use the appropriate alarm settings to alert to dangerously low or harmful high blood sugar levels, according to a study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill. This variability makes the monitors less useful in tracking glucose levels.
Duration and poor quality of sleep associated with greater risk for diabetes
Fewer than six hours or more than 10 hours of sleep, and poor quality of sleep are associated with a greater risk for diabetes, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Early time-restricted feeding improves blood sugar levels
Early-time restricted feeding, a type of intermittent fasting, improved fluctuations in blood glucose levels and decreased time above range, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Gestational diabetes cases increased during the COVID-19 pandemic
More pregnant women developed gestational diabetes during the COVID-19 pandemic than in the preceding two years, according to research being presented on Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Black patients with plaque build-up in arteries in the legs more likely to have a stroke, heart attack or amputation than white patients
A new study from Keck Medicine of USC has uncovered significant racial disparities in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) among Black and white patients in the United States.
Even with insurance, many patients with diabetes turn to GoFundMe to offset high cost of care
An analysis of medical crowdfunding campaigns reveals the types of expenses that patients with diabetes may struggle to afford. The data showed that even insured patients with diabetes used GoFundMe to offset the excess costs of treatment beyond insulin, such as uncovered co-pays, indirect care, and alert dogs. The findings are published in Annals of Internal Medicine.
Blocking Signals from Receptor Involved in Fat Metabolism, Inflammation Improves Fatty Liver and Insulin Resistance in Mice
Article title: Inhibition of GPR120 signaling in intestine ameliorates insulin resistance and fatty liver under high-fat diet feeding Authors: Takuma Yasuda, Norio Harada, Tomonobu Hatoko, Atsuhiko Ichimura, Eri Ikeguchi-Ogura, Yuki Murata, Naoki Wada, Sakura Kiyobayashi, Shunsuke Yamane, Akira Hirasawa, Nobuya…
Sea cucumbers: the marine delicacy that can deter diabetes
They’re a marine delicacy loved across Asia, but the humble sea cucumber is also proving to be a key ingredient in preventing diabetes, according to new research from the University of South Australia.
High copayments for novel therapies may reduce patients’ medication adherence
UCLA-led study shows that patients with diabetes and heart failure who have high medication copayments for novel therapies have a significantly lower chance of consistently adhering to these medications.
New Penn Medicine Study Uncovers Key Details of Fat Cells, Advancing Potential Treatments for Obesity, Diabetes
New research has unlocked insights into how “good fat” tissue could potentially be harnessed to combat obesity and remove glucose from the blood, helping to control diabetes. Published today in Science Advances, the work is a collaboration between researchers with the Perelman School of Medicine at the University of Pennsylvania and University of Cambridge, Free University of Brussels and University of East Anglia.
ENDO 2023 press conferences to highlight emerging technology and diabetes research
Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society’s ENDO 2023 news conferences June 15-18.
A New Strategy to Break Through Bacterial Barriers in Chronic Treatment-Resistant Wounds
Researchers in UNC’s School of Medicine’s department of Microbiology and Immunology and the UNC-NC State Joint Department of Biomedical Engineering have developed a new strategy to improve drug-delivery into chronic wounds infections.
Vitamin K helps protect against diabetes
Canadian researchers have identified a new role for vitamin K and gamma-carboxylation in beta cells and their potentially protective role in diabetes, achieving a first in 15 years of basic research.
New study finds that Fitterfly Diabetes Digital Therapeutics Program Improves Blood Sugar Levels and Promotes Weight Loss in Patients With Type 2 Diabetes
Fitterfly’s diabetes digital therapeutics program shows real-world effectiveness in improving glycemic control and weight management among people with type 2 diabetes mellitus
Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants
Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.
Too Much Insulin Can Be as Dangerous as Too Little
UC San Diego researchers describe a key player in the defense mechanism that safeguards against excessive insulin in the body, which can be as harmful as too little.
nPOD honors Estefania Quesada Masachs for type 1 diabetes discoveries
La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator of the Year Award from the Network for Pancreatic Organ donors with Diabetes (nPOD). This prestigious award recognizes Quesada Masachs’ groundbreaking research in type 1 diabetes.
Fasting diet reduces risk markers of type 2 diabetes
A fasting diet which focuses on eating early in the day could be the key to reducing the risk of developing type 2 diabetes, following the largest study in the world to date.
Diabetes Drug Improves Kidney Function and Inflammation
Article title: Reno-protective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system Authors: Xin Chen, Denis Delić, Yaochen Cao, Linghong Shen, Qin Shao, Zheyu Zhang, Hongwei Wu, Ahmed A. Hasan, Christoph…
Prototype taps into the sensing capabilities of any smartphone to screen for prediabetes
Researchers at the University of Washington have developed GlucoScreen, a system that could enable people to self-screen for prediabetes.
University Hospitals Research Published in New England Journal of Medicine Shows Minimally Invasive Procedure Saves Most Patients with Severe Vascular Disease from Amputation
A study, co-led by University Hospitals Harrington Heart & Vascular Institute, could lead to the first FDA approval of a therapy giving thousands of patients hope for an alternative to amputation.
Bridging the Gap: addressing medical and social needs improves diabetes care and outcomes
Housed at the University of Chicago Medicine, the Bridging the Gap: Reducing Disparities in Diabetes Care Initiative has published the results of their five-year project aimed at addressing disparities in diabetes care nationwide.
A Registered Dietitian’s Reaction to the New FDA Proposed Rule on Salt
According to the American Heart Association, roughly 90% of Americans are overdoing it on salt, consuming over twice the daily recommended amount. The U.S. Food and Drug Administration (FDA) announced recently it was proposing a rule to allow the use of salt…
New form of omega-3 could prevent visual decline with Alzheimer’s disease
For the first time, researchers have developed a form of the omega-3 fatty acid docosahexaenoic acid (DHA) that is capable of crossing into the eye’s retina to ward off visual declines related to Alzheimer’s disease, diabetes and other disorders.
Use age, not weight, to screen for diabetes
All racial/ethnic minority groups develop diabetes at lower weights than white adults
The new insulin price cap: What you need to know
In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly’s move.
Incidence Rates of Diabetes Continue to Increase in Children, Young Adults
New findings from researchers at Wake Forest University School of Medicine confirm that the rates of Type 1 and Type 2 diabetes continue to increase in children and young adults. Non-Hispanic Black and Hispanic children and young adults also had higher incidence rates of diabetes.
Endocrine Society applauds Eli Lilly’s efforts to lower insulin costs
The Endocrine Society commends Eli Lilly and Company for taking steps to reduce insulin prices and make insulin affordable for more people with diabetes.
Cleveland Clinic Study Finds Common Artificial Sweetener Linked to Higher Rates of Heart Attack and Stroke
New Cleveland Clinic research showed that erythritol, a popular artificial sweetener, is associated with an increased risk of heart attack and stroke. Findings were published today in Nature Medicine.
Phase 3 Trial Finds Oral Empagliflozin Provided Safe Glycemic Control in Children with Type 2 Diabetes
Researchers recently completed a phase 3 clinical trial that assessed the efficacy and safety of two different classes of oral agents for the treatment of type 2 diabetes in young people aged 10-17 years.
Drug Linked to Lower Risk of Dementia in People with Diabetes
People with diabetes are twice as likely to develop dementia as those without the disease. In a new study, people with newly diagnosed type 2 diabetes who took the diabetes drug pioglitazone were less likely to later develop dementia than those who did not take the drug. The study is published in the February 15, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Migraine Drug Shows Promise in Treatment of Acute Kidney Injury
The drug lasmiditan, which is used to treat migraines, shows promise as a possible treatment for acute kidney injury, according to a new study from the University of Arizona.
Overweight and Obesity in People With Type 1 Diabetes Nearly Same as General Population
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that Americans with type 1 diabetes had overweight or obesity at almost the same high rates observed in persons without diabetes.
The Medical Minute: Consider your A1C levels to monitor heart health
It’s not all about the cholesterol when it comes to heart health. A Penn State Health thoracic surgeon tells you all you need to know about A1C.
Phthalate exposure may increase diabetes risk in women
Endocrine-disrupting chemicals (EDCs) in plastics may contribute to diabetes risk in women, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Endocrine Society praises State of the Union attention to insulin affordability
The Endocrine Society applauds President Biden’s call to rein in soaring insulin prices for those with private insurance and urges Congress to take immediate action.
New way to reduce progression of diabetic kidney disease discovered
A new way to reduce progression of diabetic kidney disease, affecting 40% of people with diabetes, has been discovered by scientists. The University of Bristol-led study published today [7 February] in JCI Insight, could help the 4.8 million people in the UK with diabetes who are four times more likely to need either dialysis or a kidney transplant.
UT Southwestern researchers identify risk factors for unsuccessful bunion surgery
A study by UT Southwestern researchers has identified three factors that increase the risk that bunion surgery will fail to fix this painful foot condition. The findings, published in The Journal of Foot and Ankle Surgery, provide information that surgeons can use to counsel patients considering this elective procedure.
Risks associated with control of blood sugar in the ICU
Problems may arise in ICU patients with diabetes if their glucose levels are reduced to normal, non-diabetic levels. Researchers are still trying to unravel how the body measures glucose levels.
Language of Care: University of Utah Health Researchers Co-Design Health Care With the Deaf Community
Navigating health care is hard enough when English is your first language—imagine the difficulty when American Sign is your first language. How can we bridge the linguistic and cultural gaps needed to better care for patients? University of Utah Health is proud to present Language of Care, an incredible short film of how a community of Deaf patients are breaking barriers by co-designing their own care with U of U Health researchers.
Media registration open for ENDO 2023
Members of the media can now register to cover the latest advances in hormone health and science at ENDO 2023, the Endocrine Society’s annual meeting being held June 15-18, in Chicago, Illinois.
Study reveals obesity-related trigger that can lead to diabetes
Researchers at Washington University School of Medicine in St. Louis have found that a defect in an enzyme called APT1 interferes with the ability to secrete insulin, contributing to the development of Type 2 diabetes in people who are overweight or obese.
Stuart Therapeutics, Inc., announces expansion of its development pipeline, additions to its Scientific Advisory Board
Stuart Therapeutics, Inc. announces that it has expanded its drug development pipeline, adding programs in diabetic macular edema and myopia.
After 40 Years of Decline, Stroke Death Rates Are Rising Again
Millennials face a greater risk of ischemic stroke death than Generation X, according to a Rutgers study.
CUVET Successfully Developed the First Stem Cell Transplantation Technology to Treat Pet Diabetes
For the first time in Thailand, a research team from Chula’s Faculty of Veterinary Science (CUVET) is the first to have successfully developed a method to culture dog pancreatic cells from stem cells and cell transplantation technology. They aim to test the method in the lab and sick animals suffering from diabetes.
Do Former Football Players Age Faster?
New research suggests that former professional football players may face accelerated aging, despite past research showing they have life spans similar or longer than the general population
In the new study, retired football players reported shorter health spans — defined as years free of disease – than men in the general population
Two age-related diseases — arthritis and dementia — were found more commonly among former football players, compared with men of the same age in the general population
Additionally, hypertension and diabetes were more common among younger former players, those ages 25 to 29, compared with same-age men from the general population.
The results warrant further study to define the biochemical, cellular, and physiologic mechanisms behind premature aging in former football players
Racial, ethnic, socioeconomic disparities in insulin pump use have persisted over 20 years
While use of insulin pumps to manage type 1 diabetes has grown over 20 years, there has been no improvement in racial, ethnic, and socioeconomic disparities in their use.